A Randomized, Double-Blind Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First Line HER-2 Positive Metastatic Breast Cancer (BR004)
A Randomized, Double-Blind Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First Line HER-2 Positive Metastatic Breast Cancer (BR004)
Trial Category:
Breast
Phase
III
Contact(s)
